mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
bid1870 |
gCSI |
pan-cancer |
AAC |
0.031 |
0.6 |
mRNA |
pifithrin-mu |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.6 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
LY-2157299 |
CTRPv2 |
pan-cancer |
AAC |
0.042 |
0.6 |
mRNA |
JW-480 |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.6 |
mRNA |
lapatinib |
gCSI |
pan-cancer |
AAC |
-0.029 |
0.6 |
mRNA |
GSK-J4 |
CTRPv2 |
pan-cancer |
AAC |
0.055 |
0.6 |
mRNA |
BEC |
CTRPv2 |
pan-cancer |
AAC |
0.04 |
0.6 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.6 |